Summary
207.34 3.41(1.67%)05/13/2024
Teleflex Incorporated (TFX)
Teleflex Incorporated (TFX)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 0.28 | -3.46 | -7.09 | -19.68 | -1.61 | -22.25 | -30.65 | 21,802.25 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 201.52 | |
| Open | 201.72 | |
| High | 203.79 | |
| Low | 201.19 | |
| Volume | 300,902 | |
| Change | 0.56 | |
| Change % | 0.28 | |
| Avg Volume (20 Days) | 373,947 | |
| Volume/Avg Volume (20 Days) Ratio | 0.80 | |
| 52 Week Range | 177.63 - 262.97 | |
| Price vs 52 Week High | -23.37% | |
| Price vs 52 Week Low | 13.45% | |
| Range | -0.10 | |
| Gap Up/Down | -3.32 | |
Fundamentals | ||
| Market Capitalization (Mln) | 9,765 | |
| EBIDTA | 743,744,000 | |
| PE Ratio | 27.3950 | |
| PEG Ratio | 2.4788 | |
| WallStreet Target Price | 264.50 | |
| Book Value | 94.4090 | |
| Earnings Per Share | 7.5700 | |
| EPS Estimate Current Quarter | 3.2600 | |
| EPS Estimate Next Quarter | 3.1200 | |
| EPS Estimate Current Year | 13.7300 | |
| EPS Estimate Next Year | 15.2600 | |
| Diluted EPS (TTM) | 7.5700 | |
| Revenues | ||
| Profit Marging | 0.1198 | |
| Operating Marging (TTM) | 0.1270 | |
| Return on asset (TTM) | 0.0434 | |
| Return on equity (TTM) | 0.0845 | |
| Revenue TTM | 2,974,489,088 | |
| Revenue per share TTM | 63.3130 | |
| Quarterly Revenue Growth (YOY) | 0.0210 | |
| Quarterly Earnings Growth (YOY) | -0.6030 | |
| Gross Profit (TTM) | 1,550,087,000 | |
| Dividends | ||
| Dividend Share | 1.3600 | |
| Dividend Yield | 0.0066 | |
| Valuations | ||
| Trailing PE | 27.3950 | |
| Forward PE | 15.7233 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.2744 | |
| Revenue Enterprise Value | 3.9684 | |
| EBITDA Enterprise Value | 15.5067 | |
| Shares | ||
| Shares Outstanding | 47,101,200 | |
| Shares Float | 46,909,666 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.26 | |
| Institutions (%) | 98.55 | |
05/13 08:51 EST - Zacks Investment Research
Teleflex (TFX) Expands Vascular Access Portfolio With New Launch
Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.
Teleflex (TFX) Expands Vascular Access Portfolio With New Launch
Teleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.
05/06 14:56 EST - Zacks Investment Research
Unlocking Teleflex (TFX) International Revenues: Trends, Surprises, and Prospects
Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Unlocking Teleflex (TFX) International Revenues: Trends, Surprises, and Prospects
Evaluate Teleflex's (TFX) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
05/03 13:16 EST - Zacks Investment Research
Teleflex (TFX) Q1 Earnings Beat Estimates, Margins Rise
Teleflex's (TFX) first-quarter 2024 results reflect growth across the majority of the company's product families in EMEA.
Teleflex (TFX) Q1 Earnings Beat Estimates, Margins Rise
Teleflex's (TFX) first-quarter 2024 results reflect growth across the majority of the company's product families in EMEA.
05/02 10:36 EST - Zacks Investment Research
Compared to Estimates, Teleflex (TFX) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Compared to Estimates, Teleflex (TFX) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05/02 08:46 EST - Zacks Investment Research
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates
Teleflex (TFX) came out with quarterly earnings of $3.21 per share, beating the Zacks Consensus Estimate of $3.07 per share. This compares to earnings of $3.09 per share a year ago.
Teleflex (TFX) Tops Q1 Earnings and Revenue Estimates
Teleflex (TFX) came out with quarterly earnings of $3.21 per share, beating the Zacks Consensus Estimate of $3.07 per share. This compares to earnings of $3.09 per share a year ago.
05/02 07:17 EST - Reuters
Teleflex beats quarterly profit estimates on healthy demand for medical devices
Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices.
Teleflex beats quarterly profit estimates on healthy demand for medical devices
Teleflex reported a better-than-expected first-quarter profit on Thursday, on the back of strong demand for its medical devices.
05/01 12:46 EST - Zacks Investment Research
Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.
Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?
Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.
05/01 10:21 EST - Zacks Investment Research
Ahead of Teleflex (TFX) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Teleflex (TFX) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Ahead of Teleflex (TFX) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Evaluate the expected performance of Teleflex (TFX) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
04/30 06:30 EST - GlobeNewsWire
Teleflex to Present at the BofA Securities 2024 Health Care Conference
WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2024, at 2:20 p.m. (PT).
Teleflex to Present at the BofA Securities 2024 Health Care Conference
WAYNE, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the BofA Securities 2024 Health Care Conference at the Encore Hotel in Las Vegas, Nevada, on Tuesday, May 14, 2024, at 2:20 p.m. (PT).
04/18 06:30 EST - GlobeNewsWire
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024.
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
WAYNE, Pa., April 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024.
04/08 09:21 EST - Zacks Investment Research
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.
Teleflex (TFX) Debuts the New Unified UroLift 2 System With ATC
Teleflex's (TFX) new UroLift 2 System with the ATC platform is designed to treat all prostate types.
03/11 10:20 EST - Zacks Investment Research
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
Here's Why You Should Retain Teleflex (TFX) Stock for Now
Investors are optimistic about Teleflex (TFX) on robust growth in the Vascular business and strong Urolift prospects.
02/23 09:40 EST - Zacks Investment Research
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Falls
Teleflex (TFX) surpasses earnings and revenue estimates in the fourth quarter of 2023.
Teleflex (TFX) Q4 Earnings Top Estimates, Operating Margin Falls
Teleflex (TFX) surpasses earnings and revenue estimates in the fourth quarter of 2023.
02/22 10:36 EST - Zacks Investment Research
Compared to Estimates, Teleflex (TFX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Compared to Estimates, Teleflex (TFX) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for Teleflex (TFX) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
02/22 08:46 EST - Zacks Investment Research
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates
Teleflex (TFX) came out with quarterly earnings of $3.38 per share, beating the Zacks Consensus Estimate of $3.26 per share. This compares to earnings of $3.52 per share a year ago.
Teleflex (TFX) Q4 Earnings and Revenues Surpass Estimates
Teleflex (TFX) came out with quarterly earnings of $3.38 per share, beating the Zacks Consensus Estimate of $3.26 per share. This compares to earnings of $3.52 per share a year ago.
02/20 06:30 EST - GlobeNewsWire
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
WAYNE, Pa., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 45th Annual Raymond James Institutional Investors Conference at the JW Marriott Orlando Grande Lakes, Orlando, FL, on Tuesday, March 5, 2024, at 1:40 p.m. (ET).
02/15 11:06 EST - Zacks Investment Research
Analysts Estimate Teleflex (TFX) to Report a Decline in Earnings: What to Look Out for
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Teleflex (TFX) to Report a Decline in Earnings: What to Look Out for
Teleflex (TFX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
02/08 06:30 EST - GlobeNewsWire
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 22, 2024.
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
WAYNE, Pa., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its fourth quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, February 22, 2024.
02/07 17:46 EST - InvestorPlace
3 Top Stock Picks from America's Leading SMID-Cap Fund
There are small-cap funds, and there are mid-cap funds, and those invest in both. These are what you call SMID-Cap funds.
3 Top Stock Picks from America's Leading SMID-Cap Fund
There are small-cap funds, and there are mid-cap funds, and those invest in both. These are what you call SMID-Cap funds.